6/5/2020 | DD | Achaogen amended plan of liquidation deemed effective as of May 29
|
5/29/2020 | DD | Achaogen amended plan of liquidation confirmed by bankruptcy court
|
4/21/2020 | DD | Achaogen disclosure statement approved; plan hearing set for May 28
|
4/3/2020 | DD | Achaogen records $412,000 February loss from operations, no revenue
|
2/7/2020 | DD | Achaogen records $611,000 December loss from operations, no revenue
|
1/9/2020 | DD | Achaogen granted court approval of $4.5 million sale of China assets
|
1/3/2020 | DD | Achaogen wins plan extension to complete sales, pursue Chapter 11 plan
|
1/3/2020 | DD | Achaogen records $436,000 November loss from operations; no revenue
|
12/30/2019 | DD | Achaogen seeks court approval of $4.5 million sale of China assets
|
12/20/2019 | DD | Achaogen intellectual property sale letter of intent further amended
|
12/3/2019 | DD | Achaogen loss from operations $509,000 in October; revenue up
|
11/27/2019 | DD | Achaogen intellectual property sale letter amended amid negotiations
|
10/31/2019 | DD | Achaogen OK’d to enter letter of intent to sell intellectual property
|
10/23/2019 | DD | Achaogen looks to enter letter of intent to sell intellectual property
|
10/1/2019 | DD | Achaogen operating loss grows to $3.79 million in August; revenue up
|
8/30/2019 | DD | Achaogen wins plan extension to close sale, conclude Chapter 11 case
|
8/14/2019 | DD | Achaogen asks court for four-month extension of exclusivity periods
|
7/29/2019 | DD | Achaogen closes sale of plazomicin rights sale, announces loan default
|
6/27/2019 | DD | Achaogen secures court OK for $16 million sale of company assets
|
6/6/2019 | DD | Achaogen announces auction results of company assets
|
6/5/2019 | DD | Achaogen reports $1.19 million operating loss for April 15-April 30
|
5/1/2019 | DD | Achaogen asset sale procedures OK’d; auction scheduled for June 3
|
4/25/2019 | DD | Achaogen official unsecured creditors committee named by U.S. Trustee
|
4/18/2019 | BKCVDDEMHY | Prospect News reports four new defaults for week of April 11-April 17
|
4/16/2019 | DD | Achaogen wins interim approval to access $4.3 million of DIP financing
|
4/15/2019 | DD | Achaogen files bankruptcy, seeks approval of asset sale procedures
|
6/2/2016 | PP | Achaogen to conduct $25.2 million private placement of common stock
|
6/2/2016 | PP | Achaogen will conduct $25 million private placement of common stock
|
9/1/2015 | PP | Achaogen arranges $30 million at-the-market offering of stock
|
3/17/2014 | PP | Achaogen greenshoe exercised in its $82.8 million IPO of common stock
|
3/12/2014 | PP | Achaogen prices $72 million initial public offering of stock at $12.00
|
3/10/2014 | PP | Achaogen to price IPO of 5 million shares between $12.00 and $14.00
|
1/24/2014 | PP | Achaogen announces plans to price its initial public offering of stock
|
10/10/2006 | BT | Achaogen raises $26 million in series B financing
|
1/31/2006 | BT | Isis Pharmaceuticals licenses antibiotics to Achaogen for $1.5 million in stock
|